We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$511B
AUM Growth
+$21.9B
Cap. Flow
+$7.52B
Cap. Flow %
1.47%
Top 10 Hldgs %
16.29%
Holding
6,226
New
458
Increased
2,669
Reduced
2,117
Closed
420

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$3.61B
2
OXY icon
Occidental Petroleum
OXY
+$1.36B
3
MRK icon
Merck
MRK
+$913M
4
V icon
Visa
V
+$801M
5
T icon
AT&T
T
+$771M

Sector Composition

Rank Sector Weight
1 Technology 12.6%
2 Financials 12.17%
3 Healthcare 9.21%
4 Consumer Discretionary 8.57%
5 Industrials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BW icon
5151
Babcock & Wilcox
BW
$1.38B
$30K ﹤0.01%
9,020
+5,840
+184% +$22.5K
CMCT
5152
Creative Media & Community Trust
CMCT
$13.5M
0
CSPI icon
5153
CSP Inc
CSPI
$81M
$30K ﹤0.01%
4,000
NATR icon
5154
Nature's Sunshine
NATR
$282M
$30K ﹤0.01%
3,487
+622
+22% +$5.82K
BCIC
5155
BCP Investment Corp
BCIC
$95.7M
$30K ﹤0.01%
1,275
+653
+105% +$18.4K
SRTY icon
5156
ProShares UltraPro Short Russell2000
SRTY
$67.7M
$30K ﹤0.01%
12
+2
+20% +$4.95K
XFOR icon
5157
X4 Pharmaceuticals
XFOR
$435M
$30K ﹤0.01%
64
+57
+814% +$29K
IDEX
5158
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$30K ﹤0.01%
112
+94
+522% +$20.4K
NYMX
5159
DELISTED
Nymox Pharmaceutical Corp
NYMX
$30K ﹤0.01%
19,191
-7,722
-29% -$13.5K
SHSP
5160
DELISTED
SharpSpring, Inc.
SHSP
$30K ﹤0.01%
+2,353
New +$39.4K
DOVA
5161
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$30K ﹤0.01%
2,243
-631
-22% -$6K
NRCG
5162
DELISTED
NRC Group Holdings Corp.
NRCG
$30K ﹤0.01%
2,788
+12
+0.4% +$106
ANIX icon
5163
Anixa Biosciences
ANIX
$111M
$29K ﹤0.01%
8,436
+5,590
+196% +$23.6K
FAS icon
5164
Direxion Daily Financial Bull 3x ETF
FAS
$2.47B
$29K ﹤0.01%
400
+244
+156% +$17K
IX icon
5165
ORIX
IX
$43.2B
$29K ﹤0.01%
1,900
-7,465
-80% -$107K
LQDA icon
5166
Liquidia Corp
LQDA
$8.02B
$29K ﹤0.01%
3,687
+1,958
+113% +$18.4K
TPST icon
5167
Tempest Therapeutics
TPST
$18.5M
$29K ﹤0.01%
13
+10
+333% +$29.4K
WPS
5168
DELISTED
iShares International Developed Property ETF
WPS
$29K ﹤0.01%
758
-165,280
-100% -$6.3M
FRTA
5169
DELISTED
Forterra, Inc
FRTA
$29K ﹤0.01%
5,902
+497
+9% +$2.42K
ADMA icon
5170
ADMA Biologics
ADMA
$2.23B
$28K ﹤0.01%
7,509
+1,259
+20% +$5.56K
E icon
5171
ENI
E
$80.2B
$28K ﹤0.01%
848
-2,522
-75% -$83.3K
EYPT icon
5172
EyePoint Inc
EYPT
$1.09B
$28K ﹤0.01%
+1,700
New +$28.6K
FGD icon
5173
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.59B
$28K ﹤0.01%
1,225
GAB icon
5174
Gabelli Equity Trust
GAB
$1.79B
$28K ﹤0.01%
4,604
RMNI icon
5175
Rimini Street
RMNI
$449M
$28K ﹤0.01%
5,418
+2,892
+114% +$14.6K

Similar funds

JP Morgan Chase's Q2 2019 Portfolio in Review

As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
  • JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
  • JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
  • JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
  • JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
  • JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
  • JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.

Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.